Skip to main content

Want a detailed portfolio tracker?

SOMNUS MEDICAL TECHNOLOGIES (SOMN) EBITDA (2008 - 2026)

SOMNUS MEDICAL TECHNOLOGIES (SOMN) EBITDA from Jun 30, 2008 to Mar 31, 2026. The TTM SOMNUS MEDICAL TECHNOLOGIES (SOMN) EBITDA is $5.14B. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual EBITDA

Quarterly EBITDA

SOMNUS MEDICAL TECHNOLOGIES (SOMN) EBITDA CAGR table

PeriodCAGR
1 Year TTM-9.68%
3 Years TTM+9.12%
5 Years TTM+6.18%
10 Years TTM+3.77%
All Time TTM+5.02%

Annual EBITDA change of SOMNUS MEDICAL TECHNOLOGIES (SOMN)

YearEBITDAChange
2026$1.58B-69.36%
2025$5.17B-3.74%
2024$5.37B+20.08%
2023$4.47B+5.90%
2022$4.22B+63.94%
2021$2.58B-26.32%
2020$3.50B+56.21%
2019$2.24B+207.84%
2018$727M+13.95%
2017$638M-81.67%
2016$3.48B-4.11%
2015$3.63B+20.64%
2014$3.01B+17.55%
2013$2.56B-31.74%
2012$3.75B+7.51%
2011$3.49B+13.73%
2010$3.07B+17.74%
2009$2.60B-4.34%
2008$2.72B+4.01%
2007$2.62BN/A

Comparison SOMNUS MEDICAL TECHNOLOGIES (SOMN) five years EBITDA CAGR with competitors

SOMNUS MEDICAL TECHNOLOGIES (SOMN) five years EBITDA CAGR is 6.18%.